Detalhe da pesquisa
1.
CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer.
Br J Cancer
; 126(10): 1470-1480, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35314795
2.
Platelet mitochondrial membrane depolarization reflects disease severity in patients with preeclampsia.
Mol Med
; 28(1): 51, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35508969
3.
A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression.
Life (Basel)
; 12(10)2022 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36294951
4.
CX3CL1 Overexpression Prevents the Formation of Lung Metastases in Trastuzumab-Treated MDA-MB-453-Based Humanized Tumor Mice (HTM).
Cancers (Basel)
; 13(10)2021 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34070094
5.
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low-Expressing Cancer In Vitro and In Vivo.
Cancer Immunol Res
; 9(7): 779-789, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33906866
6.
Differential tumor biological role of the tumor suppressor KAI1 and its splice variant in human breast cancer cells.
Oncotarget
; 9(5): 6369-6390, 2018 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29464079